Conditioned cell culture medium compositions and methods of use

Patent metadata

Field	Value
Publication number	US-9458486-B2
Application number	US-201313842129-A
Country	US
Kind code	B2
Filing date	Mar 15, 2013
Priority date	May 14, 1999
Publication date	Oct 4, 2016
Grant date	Oct 4, 2016

Abstract

Novel products comprising conditioned cell culture medium compositions and methods of use are described. The conditioned cell medium compositions of the invention may be comprised of any known defined or undefined medium and may be conditioned using any eukaryotic cell type. Once the cell medium of the invention is conditioned, it may be used in any state. Physical embodiments of the conditioned medium include, but are not limited to, liquid or solid, frozen, lyophilized or dried into a powder. Additionally, the medium is formulated with a pharmaceutically acceptable carrier as a vehicle for internal administration, applied directly to a food item or product, or formulated with a salve or ointment for topical applications. Also, the medium may be further processed to concentrate or reduce one or more factors or components contained within the medium.

First claim

What is claimed is:

1. A method for reducing or eliminating a skin wrinkle, the method comprising the step of topical application of a composition comprising:
(a) a conditioned medium comprising:
(i) a fibroblast growth factor, a platelet derived growth factor, an epidermal growth factor, vascular endothelial growth factor, a bone morphogenic protein, a transforming growth factor; an insulin like growth factor, and
(ii) collagen; and

(b) an acceptable carrier;
wherein the skin wrinkle is reduced or eliminated by topical application of the composition, and

wherein the conditioned medium does not contain a dextran and the conditioned medium is made by a process comprising the steps of:
(a) inoculating not genetically engineered, fresh, not freeze-thaw, human fetal fibroblasts onto a substrate in a nutrient medium;
(b) culturing the not genetically engineered fresh, not freeze-thaw human, fetal fibroblasts in a two dimensional culture so that the not genetically engineered, fresh, not freeze-thaw human fetal fibroblasts secrete the fibroblast growth factor, platelet derived growth factor, epidermal growth factor, vascular endothelial growth factor, bone morphogenic protein, transforming growth factor and the insulin like growth factor into the nutrient medium, until the nutrient medium becomes a conditioned medium; and
(c) removing the conditioned medium from the cultured cells,
wherein the nutrient medium contains bovine calf serum; and
wherein the composition is stable for up to 2 years in storage at −20° C.

2. The method of claim 1 , where the method fortifies the skin.

3. The method of claim 1 , wherein the composition is a cream or ointment.

4. The method of claim 1 , wherein the conditioned medium comprises keratinocyte growth factor.

5. The method of claim 1 wherein the conditioned medium comprises granulocyte colony-stimulating factor.

6. The method of claim 1 , wherein the conditioned medium comprises transforming growth factor-beta.

7. The method of claim 1 , wherein the conditioned medium comprises interleukin-6.

Assignees

• Allergan Inc
• Allergen Inc

Inventors

• Naughton Gail K
• Horwitz David L
• Applegate Mark
• Zeltinger Joan
• Mansbridge Jonathan
• Kern Andreas
• Landeen Lee K
• Ratcliffe Anthony
• Pinney R Emmett

Classifications

• A61P41/00

  Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution · CPC title

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61P39/06

  Free radical scavengers or antioxidants · CPC title

• A61P25/00

  Drugs for disorders of the nervous system · CPC title

• A23L33/10 Primary

  using additives (addition of substantially indigestible substances A23L33/21) · CPC title